S. Anna Hospital Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2007
NCT00566891
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

S. Anna Hospital

Active Ingredients

Drugs in Phase 4 Trials (2)

clopidogrel (plavix) (1 trial)

tirofiban (aggrastat) (1 trial)

Drugs in Phase 2 Trials (1)

sirolimus (rapamune) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

beta-Thalassemia (Phase 2)

Coronary Artery Disease (Phase 4)

Thalassemia (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3